You are seeing these quotes based on previous browsing related to sectors such as
Latest | Forecast | |
---|---|---|
Div Yield | 0.0% | 0.0% |
Div Cover | n/a | n/a |
Op Mrgn | -87.0% | -1,163.8% |
ROCE | 0.0% |
Latest | Forecast | |
---|---|---|
P/E | -4.6 | 0.0 |
PEG | 0.0 | -999,999.0 |
Price / Revenue | 5.0 | 23.9 |
Price / Book value | 2.8 |
Latest | Forecast | |
---|---|---|
Revenue | 86.2% | 0.0% |
PBT | 0.0% | n/a |
EPS | 0.0% | 0.0% |
DPS | n/a | 0.0% |
Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
---|---|---|---|---|---|---|---|---|
2018-09-30 | 0.13 | -10.15 | -7.00p | -1.2 | 0.0 | n/a | n/a | 0.0% |
2019-09-30 | 3.13 | -6.33 | -3.40p | -2.4 | 0.0 | n/a | n/a | 0.0% |
2020-09-30 | 5.68 | -9.17 | -5.40p | -10.5 | 0.0 | n/a | n/a | 0.0% |
2021-09-30 | 10.03 | -21.44 | -8.40p | -10.2 | 0.0 | n/a | n/a | 0.0% |
2022-09-30 | 18.69 | -17.80 | -6.10p | -9.3 | 0.0 | n/a | n/a | 0.0% |
Jounce agrees Concentra Bioscences takeover, ditches Redx Pharma Sharecast News | 27 Mar |
---|
Interim Results for the Six Months Ended 31 March | 17-May-23 14:41 |
---|---|
Notice of Interim Results | 10-May-23 14:34 |
Proposed Business Combination Formally Lapsed | 03-Apr-23 15:21 |
Termination of Proposed Business Combination | 03-Apr-23 15:18 |
Form 8.5 (EPT/RI) - Redx Pharma plc | 30-Mar-23 17:18 |